Literature DB >> 18308143

Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis.

Erika Resetkova1.   

Abstract

Inflammatory breast carcinoma (IBC) is rare, but it is the most aggressive variant of breast cancer. Because a diagnosis of IBC is usually based on the presence of typical clinical symptoms that are not always associated with certain pathologic characteristics, the diagnosis often presents a great challenge even to the most experienced clinicians. Even more, IBC has not been associated with a specific histologic tumor type. With recent epidemiologic and molecular evidence now suggesting that IBC is a distinct disease entity rather than a subtype of locally advanced breast cancer, the accurate differentiation of this disease has never been more crucial to ensuring appropriate treatment. The focus of this chapter is on the histomorphologic characteristics of IBC and its broad differential diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18308143     DOI: 10.1053/j.seminoncol.2007.11.013

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  10 in total

Review 1.  Approach to inflammatory breast cancer.

Authors:  Andrea Molckovsky; Barbara Fitzgerald; Orit Freedman; Ruth Heisey; Mark Clemons
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

Review 2.  New Treatment Strategies for the Inflammatory Breast Cancer.

Authors:  Elena Vagia; Massimo Cristofanilli
Journal:  Curr Treat Options Oncol       Date:  2021-04-24

3.  High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.

Authors:  Ismahane Bekhouche; Pascal Finetti; José Adelaïde; Anthony Ferrari; Carole Tarpin; Emmanuelle Charafe-Jauffret; Colette Charpin; Gilles Houvenaeghel; Jocelyne Jacquemier; Ghislain Bidaut; Daniel Birnbaum; Patrice Viens; Max Chaffanet; François Bertucci
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

Review 4.  Intravital microscopy in the study of the tumor microenvironment: from bench to human application.

Authors:  Emmanuel M Gabriel; Daniel T Fisher; Sharon Evans; Kazuaki Takabe; Joseph J Skitzki
Journal:  Oncotarget       Date:  2018-04-13

Review 5.  Inflammatory Breast Cancer: A Literature Review.

Authors:  Fouzia Mamouch; Narjiss Berrada; Zineb Aoullay; Basma El Khanoussi; Hassan Errihani
Journal:  World J Oncol       Date:  2018-11-23

6.  A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis.

Authors:  Emmanuel M Gabriel; Minhyung Kim; Daniel T Fisher; Catherine Mangum; Kristopher Attwood; Wenyan Ji; Debabrata Mukhopadhyay; Sanjay P Bagaria; Matthew W Robertson; Tri A Dinh; Keith L Knutson; Joseph J Skitzki; Michael B Wallace
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

Review 7.  Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research.

Authors:  R Jagsi; G Mason; B A Overmoyer; W A Woodward; S Badve; R J Schneider; J E Lang; M Alpaugh; K P Williams; D Vaught; A Smith; K Smith; K D Miller
Journal:  Breast Cancer Res Treat       Date:  2022-01-01       Impact factor: 4.872

8.  Establishment of stable expression of firefly luciferase and EGFP in a canine inflammatory mammary carcinoma cell line and tumor-bearing model in nude mice.

Authors:  Fangying Zhao; Xinqiu Li; Jiayue Liu; Di Zhang; Hongxiu Diao; Degui Lin
Journal:  Front Vet Sci       Date:  2022-08-02

9.  Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer.

Authors:  Asunción Martín-Ruiz; Laura Peña; Alfredo González-Gil; Lucía Teresa Díez-Córdova; Sara Cáceres; Juan Carlos Illera
Journal:  BMC Cancer       Date:  2018-06-04       Impact factor: 4.430

10.  CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer.

Authors:  Kazuharu Kai; Takayuki Iwamoto; Dongwei Zhang; Li Shen; Yuko Takahashi; Arvind Rao; Alastair Thompson; Subrata Sen; Naoto T Ueno
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.